Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
PS has climbed 31% in a month, yet the borrow market is pricing extreme difficulty in shorting the stock, analysts are cutting to Sell, and options traders are piling into downside protection at a rate not seen in over a year.
The lending market tells a charged story. Borrow costs have exploded from around 35% in mid-September to 239% now, a near sevenfold move in three weeks. Availability, at roughly 12%, means only one share in eight in the lending pool remains unborrowed. That is tight by any measure, though it eased back from near-total exhaustion: between September 18 and September 25, availability collapsed to effectively zero, with the 52-week low touching 0.025%. Short interest in absolute share terms nearly doubled in late September, rising from around 454,000 shares to 830,000, where it has held flat for two weeks. The ORTEX short score sits at 65.9, a level that flags meaningful short-side pressure across the composite of lending, positioning, and momentum signals.
Options positioning has swung sharply defensive at the same moment. The put/call ratio jumped to 2.0 on October 9, more than two standard deviations above its 20-day average of 1.31. That is close to the 52-week high of 2.42, and well above the sub-1.0 readings seen through mid-September when the stock was still recovering from its August lows. The combination of a near-maxed borrow market and heavy put demand suggests investors on the short side are not retreating despite the month's strong price gains.
The Street reflects the same tension. Citigroup downgraded PS to Sell on October 9, maintaining a $45 target against a current price of $54.59, a gap that frames the stock as materially overvalued at current levels. RBC Capital raised its target to $44 from $41 on October 5 while staying at Sector Perform. Jones Trading moved to Hold from Buy in late September. The consensus is now entirely Hold and Sell, with no Buy ratings remaining among the nine analysts on record. The bear case is specific: the fund trades at 41.2x forward fee-related earnings per share versus a peer median of 19.9x, PSH's NAV dropped from $81.96 to $76.93 between late August and late September, and PSUS still trades at a 20.1% discount to NAV. The bull case rests on the 98% permanent capital base, a 31% sequential rise in fee-paying AUM to $22.3 billion, FRE margins at 82.4%, and the full-quarter contribution from PSUS beginning in Q3. Those are real positives, but the gap between the $44 to $45 target cluster and a $54.59 price implies the Street believes the stock has run well past fair value in a single month.
Ownership is highly concentrated and structurally unusual for a listed vehicle. William Ackman filed a Schedule 13G in August disclosing a 45.3% stake, Pershing Square Management LLC reported 75.1% in aggregate across related entities, and Ryan Israel holds 7.8%. These are passive-form disclosures, not activist filings, and positions are as last disclosed around the 5% threshold: a holder dropping below 5% may exit without a further filing. The institutional register beyond the founding team is thin, with only 35 total institutional holders reported. Ackman gifted 10 million shares in August (transaction type G), a non-market transfer that does not signal directional conviction. His only open-market trade on record was a $1.85 million purchase at $22.61 in late April, well below current levels.
ORTEX forecasts a 68% probability that PS joins the Russell 1000 at the December 2026 Semi-Annual Review, with a rank date of October 30 and a trade date of December 11. That would require roughly $112 million of index-tracker buying over an estimated 5.6 days of normal volume. The price that decides the inclusion is $13.83, and at $54.59 the stock is 74.7% above that line, so the threshold is not in doubt. Worth noting: among 120 comparable past additions, the median move from announcement to effective date was minus 3.6%, and only 32% moved in the expected (upward) direction. The index-flow angle is therefore not a straightforward positive catalyst.
The next notable date is the October 30 rank date, which will confirm or deny the Russell inclusion call, and whether the borrow market tightens further from its current 12% availability level as that date approaches will say something about how committed short sellers are to holding their positions into a potential forced-buying event.
See the live data behind this article on ORTEX.
Open PS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
